Richard R. Furman
Cornell University(US)Weill Cornell Medicine(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Chronic Myeloid Leukemia Treatments, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia(2013)2,236 cited
- → Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia(2014)1,675 cited
- → Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia(2014)1,603 cited
- → Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome(2013)1,539 cited
- → Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib(2014)1,240 cited
- → Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies(2012)1,110 cited
- → Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia